More for Palantir, less for mRNA, and a disaster database redemption arc
Summary
The article discusses several economic updates. Palantir, a tech company, exceeded one billion dollars in revenue for one quarter. Meanwhile, funding for mRNA vaccine research has been reduced, and a climate disaster database has been given renewed support.Key Facts
- Palantir reported over one billion dollars in revenue for a recent quarter.
- The company Palantir works in the technology sector.
- Funding for research on mRNA vaccines was cut by the health department.
- mRNA vaccines are used for fighting diseases like COVID-19.
- A database that tracks climate disasters has received new support.
- The database is meant to help understand and respond to climate-related events.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.